Summary. Evidence has been obtained for the presence in vivo of alpha2D-globulin, a breakdown product of serum f10-globulin, in patients with acute and persistent hypocomplementemic glomerulonephritis. The protein has been identified by immunoelectrophoretic analysis, and the amounts present have been determined by direct measurement of specific antigenic determinants present on alpha2D. 831A-Globulin, another breakdown product of Plcglobulin, may also be present in vivo in severely hypocomplementemic patients, but its levels are much lower than those of alpha2D-globulin.
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Alpha2D-globulin has been identified by immunoelectrophoretic analysis of fresh EDTA plasma from patients with hypocomplementemic nephritis as an arc in the alpha2 region that shows a reaction of identity with the arc representing alpha2D-globulin produced by aged normal serum. 831A-Globulin was not seen in these patterns.
Measurement of specific antigenic determinants has been carried out in both fresh EDTA plasma and aged serum. In the fresh plasma, the concentration of D antigen, found on both Plw-and alpha2D-globulins, has been related to that of B antigen, found only on /31c and taken as a measure of the concentration of this protein. In the hypocomplementemic patients, the concentration of D antigen, in comparison to that of B, was greater than in the normal subjects. Similarly, in aged serum, the level of alpha2D was greater than would be expected from the amount of flic that had been broken down in vitro, measured by the concentration of ,81A.
Calculations indicated that the in vivo alpha2D level in severely hypocomplementemic patients ranged from 7.5 to 18% of that which would be found in a pool of aged normal serum in which /3ic is completely broken down. The levels tended to be lower in less severely hypocomplementemic patients, and none could be detected in normal plasma.
Only small quantities of A and D antigens are detectable in the urine of patients with hypocomplementemic nephritis. The rate of excretion is about equal to that of the normal subject.
The study indicates that the low serum levels of fl3c-globulin that may be present over long periods in patients with persistent hypocomplementemic glomerulonephritis can be ascribed, in part, to in vivo breakdown of this pro-Introduction A type of persistent glomerulonephritis has recently been described (1) (2) (3) (4) in which the serum Pie-globulin concentration remains very low over periods of many months' duration. The persistently low levels of this protein, normally the most abundant of all of the complement components in serum, could be explained in several ways. The protein may be taken up by immune complexes responsible for the disease, and indeed, immunofluorescent techniques have shown deposition of Pie-globulin as well as of IgG in the glomerular capillary walls (3) . However, over the long periods of serum depletion observed, the amounts accumulating in this manner would become very great, making continued deposition as the complete explanation unlikely.
Alternatively, the low level could be explained by diminished synthesis of Pli-globulin. Studies employing isotopically labeled ,81c have shown that the rate of disappearance of the label in hypocomplementemic subjects is identical to that in normal subjects (5) . If The method of preparation of antiserum containing high titer of antibody to the A, B, and D determinant groups of #Ic-globulin was described previously (7).
All antiserum was produced in goats. For immunoelectrophoretic determination of A antigen, the antiserum was diluted so that the addition of 44.6 jug of 61A to 1 ml of the diluted antiserum removed all but the small amount of antibody to A antigen required to produce the very faint end point precipitin arc (9) . In this determination, the supernatants were reacted against #1A contained in a dilute euglobulin precipitate of aged human serum (2 Measurement of A and D determinants in urine. A modification of the immunoelectrophoretic precipitin method (9) was used for measurement of A and D determinants in urine. Timed urine collections were made so that results could be expressed as excretion rates. From a given urine collection, samples corresponding in volume to the urine formed over periods of 10 to 120 minutes' duration were added to measured amounts of the standard antisera used for A and D determination. The mixtures were incubated for 30 minutes at 370 and for 2 days at 40, after which they were centrifuged in the cold. The entire supernatant was then placed in dialysis tubing, and the contents were pervaporated in a current of air with one end of the sac immersed in dilute buffer. The concentrated material was then squeezed from the sac, the sac rinsed, and the material made to the volume that would be used in the immunoelectrophoretic precipitin method for the volume of standard antiserum employed. We then used the concentrated supernatants to develop the immunoelectrophoretic pattern in the same manner as supernatants of serum-antiserum mixtures in the immunoelectrophoretic precipitin method. However, when the amount of serum subjected to immunoelectrophoresis was increased by enlarging the diameter of the antigen well from the usual 2 mm to 3.5 mm, an arc with the position and configuration of alpha2D became readily visible. It is illustrated in Figure 1 , A and B.
The antiserum used to produce the patterns in Figure 1 contained antibody to A and D antigens and hence allowed visualization of 8ic, P1A, and alpha2D (7) . In the bottom panel of Figure 1 , A, aged serum from a normal subject has been subjected to immunoelectrophoretic analysis, and a typical strong alpha2D arc is seen. No comparable arc is seen in the upper panel in which fresh EDTA plasma from the same normal subject has been analyzed. In the center panel is shown the pattern produced by fresh EDTA plasma obtained from a child shortly after onset of acute glomerulonephritis. Arcs of the same character and mobility as alpha2D are present, whereas no /lic or BlA arc can be identified with certainty. Figure 1 , B, is the same except that aged normal serum has undergone electrophoresis in the same agar strip with the fresh EDTA plasma from the patient with acute glomerulonephritis. The junction without spurring of the alpha2D arc of the aged normal serum with the arc produced by the patient's plasma identifies the latter as alpha2D. This observation constitutes strong evidence that alpha2D was present in the circulation in vivo.
The arc from the hypocomplementemic serum with which the 81A arc of the aged serum identifies is probably 8ic; in similar immunoelectrophoretic patterns of other patients less hypocomplementemic, a larger arc in this area that reacted with antibody to D antigen and hence interfered with the reaction of identity must of necessity have been fic-globulin. With the large antigen well, we observed arcs of the same size and position as the alpha2D arcs in Figure 1 In contrast to the A determinants, the consumption of antibody to D determinants in relation to that of B is different in the plasma of the hypocomplementemic as compared to the normal subjects. In Figure 3 , this relationship is plotted for 16 normal subjects and 6 hypocomplementemic patients (3 with acute and 3 with persistent hypocomplementemic nephritis). The concentration of D antigen in the hypocomplementemic patients is greater than would be expected for the amount of B antigen present. Again, there is some scatter of the points for the normal subjects.
A more sensitive assessment of the relation of A and D to B antigens in hypocomplementemic patients is afforded by plotting the data as ratios. In Figure 4 , the ratios of A: B and D: B are plotted against the concentration of B determinant. In the normal subjects, both ratios are relatively constant at all concentrations of Pfic. How t AGN = acute glomerulonephritis; PHGN = persistent hypocomplementemic glomerulonephritis. t Ranges for H1A in normal subjects determined previously (4), for alpha2D, in the present study. § See Figure 5 .
all five patients, biopsies gave evidence of focal inflammatory reactions in the glomeruli (4). The normal ratios of alpha2D to Jf1A in these patients indicate that if an immune reaction involving complement is occurring, it has no discernible effect on the serum content of either /81A or alpha2D.
In vivo concentration of alpha2D it plasma. The plasma concentration of alpha2s in vivo can be calculated from the measurements of B and D determinants in fresh plasma and of A and D determinants in aged serum. If we assume that alpha2D is not present in zivo in normal subjects, the data allow an estimate of the amount of D determinant contributed by ,l1c in hypocomplementemic plasma or serum. Subtracting this value from the total alpha2D concentration gives the order of magnitude of the alpha2D concentration in viz'o.
From Figure 5 it can be seen that in aged serum the ,81A concentration in milligrams per 100 ml can be multiplied by 21.3 to estimate the units of alpha2D per 100 ml derived from /61c breakdown during aging. In hypocomplementemic serum, the amount in excess of this estimate would be preformed alpha2D. Although there is considerable scatter of the data, there is a definite trend for the preformed alpha2D present in vivo to be in higher concentration in specimens with the lowest 81A concentrations. For example, at 813A levels between 5 and 10 mg per 100 ml, preformed alpha2D concentration averaged 4.2 U per ml (six patients), whereas between 30 and 45 mg per 100 ml the average was 2.1 U per nil (six patients).
As suggested by the results of immunoelectrophoretic analysis then, the concentration of this breakdown product in hypocomplementemlic patients tends to vary inversely with the level of ftic.
A similar inverse relationship probably also obtains in fresh plasma. However, it could not be demonstrated by calculations with the data for D and B antigens given in Figures 3 and 4, believe that there is virtually no excretion of this determinant, insofar as addition of increasing amounts of urine to the standard antiserum resulted in no detectable depletion of antibody, as evidenced by the lack of change in the intensity and character of the precipitin arc produced by the supernatants. The observation suggests that the urine was completely devoid of A determinants.
Alpha2D was present in measurable amounts in the urine of the normal subject and of two of the patients with nephritis. The normal adult had a rate of excretion equal to or greater than that of the patients with nephritis. In the first specimen from P.T., the rate of excretion of alpha2D of 0.75 U per hour gives a renal clearance of 0.23 ml of plasma per hour, assuming his alpha2D concentration in vizo was the same as that of his aged serum.
Although these excretion values may be erroneously low by a factor of 25 to 30% due to methodological error, it is nevertheless apparent that the excretion rates of flc-globulin and its breakdown products are almost negligible and would not account for the reduced serum levels. Discussion
Two lines of evidence, immunoelectrophoretic analysis and titration of specific antigenic determinants, indicate that a small but significant amount of alpha2D is present in vivo in hypocomplementemic patients, presumably as a breakdown product of 81c-globulin. There was no experimental evidence of its presence in normal subjects. In contrast, the data indicate that very little /31A is present in hypocomplementemic patients. The only evidence for the presence of 81A was the slightly increased ratio of A to B antigen in fresh plasma (Figure 4 ). This result is contrary to previous reports by Morse, Mufller-Eberhard, and Kunkel (10) and by Lachmann (11 Definite evidence for in zivo presence of P1G-globulin (C'31) (6, 7) was not found. The small amount of A determinant, attributed above to 31sA, could conceivably be contributed by A determinants on 81G. In this case, a moiety of the "excess" of D determinants should also be assigned to 81G-It should, however, be noted that P1G has only been produced from purified Plic in the absence of whole serum; in serum, the condition that produces this transformation presumably has as its end products P1A and alpha2D.
Although alpha2D was the only breakdown product unequivocally found in the hypocomplementemic patients, its presence constitutes further evidence for the current concept that the reducd complement level in nephritis is the result of participation of complement in an in vtvo immune reaction. One of the mechanisms by which the third component of this complex, lie, can remain reduced over long periods must therefore be in vivo breakdown. The roles of P1c deposition and of diminished synthesis in keeping concentrations low cannot be defined by the present study. 1 The present observations coincide with the investigations of Muller-Eberhard and associates (6) , who used radiolabeled /81c in detailed studies 1 In vivo breakdown of jic and persistence of breakdown products in the circulation could introduce error in the isotopic measurement of pic disappearance. If the portion of the molecule that yielded alpha2D were isotopically labeled, the breakdown product would contribute counts and the half-life calculated for jc would be erroneously long.
of the uptake and conversion of this complement component during immune hemolysis. Attachment of C'3 (,Pie) to the red cell membrane was found to be the result of the reaction of Plm with C'1,4,2a or C'4,2a sites on the red cell surface. Because one C'4,2a group could effect the binding of several hundred Pmc molecules, it was impossible to assume that the attachment was to the C'4,2a group. The point applicable to the present study was that, in addition to bound C'3, the reaction also caused conversion of large quantities of C'3 to inactive C'3, designated C'3i, or P1G. In fact, C'4,2a groups in free solution were also capable of effecting conversion to C'3i, and here none of the product was bound to cell membranes, even though red cells were suspended in the reaction medium. The results required those authors to postulate that C'4,2a groups are capable of converting, by enzymatic action, large numbers of C'3 molecules to an "activated" form. This form is unstable and can either bind to cell membranes or convert to C'31. The half-life of activated C'3 appears to be very short.
If we assume that C'4,2a groups are present in the glomerular capillary walls or on circulating complexes, the above observation can be applied to the events in hypocomplementemic nephritis. C'3, present in circulating plasma, is activated and, at least initially in the disease, is bound to surrounding glomerular structures or to complex. As the reaction proceeds, available receptors for attachment of C'3 become saturated and the majority of the molecules convert to C'3i. C'31 is presumably in turn broken down by serum factors to P1A and alpha2D. The alpha2D produced from C'31 breakdown appears to circulate for a time, whereas PAB1 must be quickly removed from the circulation. It 
